Current Pharmacological and Cosmetic Approaches for Managing Hyperpigmentation Disorders: Evaluating the Efficacy and Safety of Topical Agents, Chemical Peels, and Laser Therapies for Conditions like Melasma and Post-Inflammatory Hyperpigmentation
Hyperpigmentation disorders, such as melasma and post-inflammatory hyperpigmentation (PIH), result from the overproduction of melanin, leading to dark patches that can significantly affect a patient’s self-esteem and quality of life. Treatment strategies aim to lighten the existing pigment and prevent future discoloration using a combination of methods.
The gold standard typically begins with topical agents like hydroquinone, retinoids, or azelaic acid to inhibit melanin production, often complemented by strict sun protection. More advanced in-office treatments, including chemical peels and various laser or light-based therapies, are reserved for resistant cases, requiring careful selection to avoid worsening the condition.